Delhi Girl Suffers Deadly Neurological Complications Post COVID-19 Vaccination with Covishield, Dies Within Days


All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 

Visit and follow us on Instagram at @crg_globalresearch.


In an incident, a 22-year-old girl died of severe neurological complications after receiving the COVID-19 vaccine jab. Read to find out the symptoms you need to look out for post-vaccination.

In yet another shocking incident, a 22-year-old girl from Delhi suffered deadly neurological complications after receiving the COVID-19 vaccination and was declared brain dead at a hospital in the national capital. According to the primary reports, the girl has no history of any serious illness. “An autopsy report is awaited to confirm the cause of the death,” officials were quoted as saying.

The deceased girl’s family told a national newspaper that she was administered with the Covishield vaccine on June 2. Soon after she started developing chronic headache accompanied with high body temperature. The girl was rushed to the hospital where some of the reports suggested that she has blood clots in the brain’s venus sinuses due to which was platelet count was decreasing rapidly. According to the reports, the girl was admitted to a private hospital in Delhi’s Saket on June 14, and all the necessary arrangements were made to keep her safe. “On June 18, the girl was declared brain dead by the doctors at around 5am,” an official was quoted as saying.

The sources in NOTTO said that they since the girl died due to complications post-COVID vaccination, a postmortem report will be required to confirm whether the death was due to adverse effects of the vaccination or some other health abnormalities. “Postmortem is necessary in cases of suspected or confirmed Adverse Events Following Immunisation (AEFI) to know how vaccine related side-effects affect organs,” TOIquoted an official of NOTTO as saying.

Blood Clot Symptoms To Watch Out For After Taking Covishield

The Union health ministry had earlier listed a few symptoms of blood clot which everyone should look out for after taking the Covishield COVID-19 vaccine jab. “AEFI (Adverse Event Following Immunisation) data in India showed that there is a very miniscule but definitive risk of thromboembolic events,” the health ministry said in a statement, citing a report by the National AEFI Committee. What are these thromboembolic events? According to the experts, these refer to the formation of a clot in a blood vessel that might also break loose and be carried by the bloodstream to plug another vessel. The list of symptoms mentioned in the ministry’s advisory are:

  • Difficulty in breathing
  • Chronic chest pain
  • Pain or unexplained swelling in limbs
  • Persistent abdominal pain
  • Severe and persistent headache
  • Blurred vision or pain in eyes
  • Brain fog
  • Persistent vomiting without any reason

(Note: These symptoms, the ministry said, occur within 20 days of taking a shot — particularly Covishield)

Editor’s Note:
The article is informative but the last three paragraphs below are contradictory: the authors refute their own analysis.
India’s Covishield “vaccine” is mRNA produced in partnership with AstraZeneca  It is an experimental and  dangerous drug.

Are COVID-19 Vaccine Safe?

The recent incident has again raised questions about the safety issues of COVID-19 vaccines. Although, the real cause of the death of the girl is yet to be confirmed, questions like whether vaccines can lead to serious health complications and eventually cause death or not is lingering in everyones mind. So, when it comes to the safety part of the vaccines — yes, they are safe and some post-vaccination symptoms are common and not at all life threatening. However, make sure to consult a doctor immediately in case you develop any persistent symptoms or the ones listed above.

What Do We Know So Far?

According to the guidelines by the health officials, everybody is safe to take the vaccine jab as the trial reports have proven the efficacies of each of the doses. Are vaccines safe? Yes, based on the research reports, the vaccines for COVID-19 have a very good safety profile. COVID-19 vaccines can help your body make antibodies to fight off the virus and keep you protected and safe. To go further into this topic, here are some guidelines for all those who must avoid taking the vaccine jab.

Who Should Not Take The COVID-19 Vaccine Jab?

India is currently administering two vaccines for the COVID-19 infections — Covishield and Covaxin. Here are a few things to keep in mind when you want to get the jab: Anyone who is allergic to the ingredients of the vaccine — must avoid taking it (or consult your physician before administering). Other than this anyone who is above 18 can get the jab. 


Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Shutterstock

Articles by: Satata Karmakar

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]